Covid-19 vaccine collaborators Pfizer and BioNTech are attempting to invalidate two patents owned by their rival Moderna that they were accused of infringing last year. In petitions to the US Patent
The global patent disputes between mRNA vaccine manufacturers have once again set the patent community buzzing. While GSK launched several lawsuits at the UPC against Moderna, BioNTech and Pfizer in
BioNTech and Pfizer must pay damages to Moderna for the use of one of its patents in Germany. This was the ruling handed down today by Düsseldorf Regional Court in the dispute over mRNA vaccines. It
total 1 pages, 3 items